justbacked
← All jobs
Ratio Therapeutics

Your Desired Role

Boston, Massachusetts · TBA

Series C · $70M · 113d ago Posted 3y ago
Have your AI draft the answers and brief you on Ratio Therapeutics→

Why join Ratio Therapeutics?

The bet: one targeting platform, Ratio Therapeutics' Trillium, can both image and treat tumors, so a single scan could pick the patients and the drug. If it works, Boston-based radiopharmaceuticals could move from a niche option to a routine tool against many solid tumors. Eli Lilly and Bristol-Myers Squibb back a $70M Series C, bigger than 34% of rounds at its stage this half, for a clinical-phase company.

JustBacked's take, based on Ratio Therapeutics's own site and its funding and hiring data.

Don't see a role that meets your qualifications but you are interested in working at Ratio Therapeutics?? Upload your resume and cover letter with more information about you!

About Ratio Therapeutics

Ratio Therapeutics is committed to improving and extending the lives of cancer patients without sacrificing their quality of life. We are a team of passionate scientists, engineers, and business professionals dedicated to advancing the field of targeted radioligand therapy to enable new therapies with higher cure rates and fewer side effects. To accomplish this, we utilize our proprietary TRILLIUM™ and MACROPA™ platforms:  TRILLIUM™ allows fine-tuning of radioligand pharmacokinetics thereby enhancing the therapeutic index, while MACROPA™ simplifies the manufacturing process for the alpha-emitting isotope, actinium-225. These enabling platform technologies have resulted in an emergent pipeline of novel therapeutic candidates. We are looking for talented, dedicated, and creative individuals eager to help us advance these technologies from discovery research through clinical development. Join us in our quest to become the leading innovator in radioligand therapy and improve the lives of cancer patients and their families.